tidbit HZNP $6-7 coming--:
1. Horizon Pharma, Inc. (HZNP): Develops and commercializes medicines for the treatment of arthritis, pain, and inflammatory diseases. Market cap at $133.79M, most recent closing price at $3.97. Performance over the last quarter at 20.63%. Over the last six months, insiders were net buyers of 4,270,210 shares, which represents about 16.85% of the company's 25.35M share float.